Cooperative Agreement 2242770
Award Date
9/1/23
Completion Date
8/31/25
Dollars Obligated
$1M
Federal Agency
National Science Foundation
Awardee
Impressio Inc. (FJX5U2C4Q6K1)
Federal Grant Program
47.084
Assistance Type
Cooperative Agreement
Place of Performance
Thornton, CO 80229, USA
Similar Awards
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award to Reselute, Inc. provides $998,921 to develop a novel implantable orthopedic medical device and procedure to reduce recovery duration and infection risks associated with severe traumatic fractures of the long bones. The project aims to advance a 3D-printed, antibiotic-releasing intramedullary nail to improve upon current standard-of-care implants that are prone to...
This Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) is funding Gelastomerics LLC, a for-profit manufacturer, to develop a new hydrogel elastomer technology for medical device applications. The $305,000 award, effective May 1, 2025 through April 30, 2028, aims to establish the viability of this intrinsically lubricious elastomer as a versatile, drop-in alternative for...
This federal Project Grant award from the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships program) provides $274,997 to Flex Orthopaedics, Inc. to develop a novel ancillary implant device that can extend the lifespan of total knee replacement orthopedic implants. The project aims to prototype and validate a flexible tibial stem that can accommodate the multi-dimensional motion of the knee joint, reducing mechanical stress and wear on the primary implant....
This SBIR Phase II Cooperative Agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $1,000,000 in funding to Amphix Bio Inc. to develop a scalable manufacturing process for a novel spinal implant technology based on supramolecular polymers. The primary objectives are to: 1) manufacture the active supramolecular polymer ingredient at large scales suitable for clinical use, and 2) combine this with other materials to...
This Cooperative Agreement award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) provides $1,000,000 in funding to Winter Innovations, Inc. to develop a novel suturing device for orthopedic ligament and tendon surgical procedures. The innovation utilizes a two-part needle technology to improve surgical consistency, reduce procedure times by one-third, and decrease revision rates by nearly two-thirds compared to current...
This Project Grant award, funded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), supports the development of a novel implantable medical device to restore movement and recovery for patients undergoing reconstructive surgery. The $275,000 award to Orthomechanica, Inc., a minority-owned small business located in Corvallis, OR, will advance the design, engineering, and preclinical validation of a tendon-mounted implant system....
The National Science Foundation (NSF) awarded a $273,563 Small Business Innovation Research (SBIR) Phase I grant to Medicarbone Inc. under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The objective of this 12-month project is to design, develop, and demonstrate the feasibility of a minimally-invasive intramedullary (IM) sleeve system with an in situ, photocurable, and removable polymeric bone cement for the treatment of orthopedic fractures. The project aims to address...
The National Science Foundation (NSF) awarded a $979,298 Cooperative Agreement under its Technology, Innovation, and Partnerships (CFDA 47.084) program to Asante Bio LLC, a small disadvantaged business, to develop a Multi-Axial Filament Winding Process (3DMF) for biomanufacturing high-performance orthobiologic implants for rotator cuff repair. This two-year project aims to optimize the manufacturing, surgical delivery, biomechanical performance, and biocompatibility of the 3DMF implants, which...
This federal Project Grant award for $295,000 from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of an innovative, implantable device for treating diabetic foot ulcers. The awardee, Biodynamik, is designing and testing a low-profile, transverse tibial transport device that leverages distraction osteogenesis to stimulate soft tissue growth and restore blood circulation to the diseased limb, providing a new treatment...
This National Science Foundation (NSF) Cooperative Agreement award, provided through the NSF Technology, Innovation, and Partnerships (CFDA #47.084) program, funds the development of a novel, fully implantable craniofacial distraction system by Ostiio LLC, a medical device company based in Philadelphia, PA. The $1,000,000 award aims to produce a magnetic, subcutaneous distraction device capable of gradually correcting skeletal abnormalities affecting craniomaxillofacial functions such as...